STN: 125761
Proper Name: Anthrax Vaccine Adsorbed, Adjuvanted
Tradename: CYFENDUS
Manufacturer: Emergent Product Development Gaithersburg Inc.
Indication:

• For post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs

Product Information

• Package Insert - CYFENDUS
• Patient Information - CYFENDUS

Supporting Documents

• July 20, 2023 Approval Letter - CYFENDUS